PMV Pharmaceuticals (PMVP) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced with introductions and outlined a virtual format, allowing real-time online voting until polls closed.

• Agenda was displayed via webcast, and formal business was prioritized before Q&A.

• Legal counsel, independent auditors, and election inspector were present, and meeting rules were provided to attendees.

Board and executive committee updates

• Board size reduced from seven to six members due to Dr. Heyman not standing for re-election.

• David Mack and Laurie Stelzer nominated and elected as Class III directors for terms expiring in 2029.

Shareholder proposals

• Three proposals presented: election of two Class III directors, advisory approval of executive compensation, and ratification of Ernst & Young as auditor.

• Board recommended approval of all proposals.